Alembic Pharmaceuticals surges on securing USFDA’s final approval for ‘Dapagliflozin Tablets’
Mumbai, April 7 (Udaipur Kiran): Alembic Pharmaceuticals is currently trading at Rs. 681.40, up by 25.25 points or 3.85 % from its previous closing of Rs. 656.15 on the BSE. The scrip opened at Rs. 654.80 and has touched a high and low of Rs. 683.30 and Rs. 653.00 respectively. So far 8313 shares were … Read more





